产业经济医疗周观点：国家医保局：36个项目纳入《综合诊查类医疗服务价格项目立项指南（试行）》

Group 1 - The report highlights that the National Healthcare Security Administration has included 36 projects in the "Guidelines for the Establishment of Comprehensive Diagnosis and Treatment Medical Service Price Projects (Trial)" to standardize medical service pricing across provinces, promoting service quality and convenience for patients [12][2]. - The medical index showed negative returns across six sub-industries this week, with the worst performers being medical services (-5.51%) and chemical pharmaceuticals (-4.08%) [13][2]. - The new pricing guidelines emphasize service output orientation, categorizing projects into diagnosis fees, bed fees, and transport fees, and introducing new projects like "palliative care" and "air medical transport" to meet the needs of an aging society [12][2]. Group 2 - The report reviews the performance of the pharmaceutical sector from November 11 to November 15, noting that the medical commercial sector had a decline of 1.52% and medical devices dropped by 3.37% [13][2]. - The valuation levels for the pharmaceutical sector indicate that chemical pharmaceuticals have the highest PE ratio at 63.06 times, followed by biological products at 52.68 times [13][2]. - The report tracks the 16th China Pharmaceutical Entrepreneurs, Scientists, and Investors Conference, emphasizing the importance of international expansion and mergers for Chinese pharmaceutical companies to achieve global competitiveness [18][2].